Cytori Therapeutics Inc Warrant
CYTXW
CYTXW was delisted on the 14th of December, 2018.
3 hedge funds and large institutions have $3K invested in Cytori Therapeutics Inc Warrant in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
200% more capital invested
Capital invested by funds: $1K → $3K (+$2K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$5.17K |
Top Sellers
CYTXW Hedge Fund Activity: Q2 2018 in Review
3 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q2 2018, worth a combined $3K — up 200% from $1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CYTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $5.17K.
- 3 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q2 2018, up from 2 in Q1 2018.
- Funds reported $3K of Cytori Therapeutics Inc Warrant stock for Q2 2018, up 200% quarter-over-quarter.
- 1 fund opened new Cytori Therapeutics Inc Warrant positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest Cytori Therapeutics Inc Warrant buyer in Q2 2018 was Sabby Management, an estimated $5.17K added.
Based on aggregated 13F filings for Q2 2018.